NewGenIvf Group (NASDAQ:NIVF – Get Free Report) and Mangoceuticals (NASDAQ:MGRX – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, valuation, earnings and profitability.
Risk & Volatility
NewGenIvf Group has a beta of 0.26, meaning that its stock price is 74% less volatile than the S&P 500. Comparatively, Mangoceuticals has a beta of 1.76, meaning that its stock price is 76% more volatile than the S&P 500.
Earnings & Valuation
This table compares NewGenIvf Group and Mangoceuticals”s top-line revenue, earnings per share and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
NewGenIvf Group | $5.14 million | 0.58 | $130,000.00 | N/A | N/A |
Mangoceuticals | $866,792.00 | 69.58 | -$9.21 million | ($6.45) | -0.38 |
Profitability
This table compares NewGenIvf Group and Mangoceuticals’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
NewGenIvf Group | N/A | N/A | N/A |
Mangoceuticals | -1,053.93% | -243.34% | -200.73% |
Analyst Ratings
This is a breakdown of recent ratings and recommmendations for NewGenIvf Group and Mangoceuticals, as provided by MarketBeat.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
NewGenIvf Group | 0 | 0 | 0 | 0 | N/A |
Mangoceuticals | 0 | 0 | 0 | 0 | N/A |
Insider and Institutional Ownership
66.2% of NewGenIvf Group shares are held by institutional investors. Comparatively, 56.7% of Mangoceuticals shares are held by institutional investors. 31.8% of NewGenIvf Group shares are held by insiders. Comparatively, 39.3% of Mangoceuticals shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Summary
NewGenIvf Group beats Mangoceuticals on 6 of the 9 factors compared between the two stocks.
About NewGenIvf Group
A SPAC I Acquisition Corp. is a blank check company. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or related business combination with one or more businesses. A SPAC I Acquisition Corp. is based in Singapore.
About Mangoceuticals
Mangoceuticals, Inc. develops, markets, and sells various men's wellness products and services through a telemedicine platform in the United States. It offers erectile dysfunction (ED) products under the Mango brand and hair loss products under the Grow brand name. The company markets and sells these branded ED and hair loss products online through its website at MangoRx.com. Mangoceuticals, Inc. has a marketing agreement with Marius Pharmaceuticals, LLC to market and sell KYZATREX, an oral testosterone replacement therapy product under the PRIME program. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.
Receive News & Ratings for NewGenIvf Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NewGenIvf Group and related companies with MarketBeat.com's FREE daily email newsletter.